Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 86.58K | $ 113.42K | $ 296.11K | $ 59.49K | $ 132.17K |
Total Assets | $ 11.48M | $ 11.76M | $ 12.95M | $ 8.96M | $ 9.35M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 70.42K | $ 44.83K | $ 234.14K | $ 35.73K | $ 27.89K |
Stockholders Equity | $ 11.41M | $ 11.72M | $ 12.72M | $ 8.93M | $ 9.33M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |